Abiopharma

News list

Hillstream BioPharma Inc. (was rebranding to Tharimmune Inc (THAR)) (HILS)

Business News
Sept. 04, 2025, 12:01 UTC

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

Full text

Register to leave comments
There are no comments here yet...